The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.

Inclusion Criteria:

1. Followed by ischemic or hemorrhagic stroke
2. Between 1 week and 6 months or >1 year has passed since the date of the event
3. Being between 55 and 85 years of age

Exclusion Criteria:

1. The patient has additional neurological conditions besides stroke
2. The patient has a psychiatric condition
3. History of recurrent stroke
4. BMD scan performed within the last year for stroke patients
5. Having received osteoporosis treatment before or after the stroke
6. The patient having a fragility fracture before the stroke
7. The patient having a hip fracture or hip prosthesis
8. The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture)
9. The patient has an additional disease or medication use that could cause secondary osteoporosis
10. The patient's stroke did not cause physical function loss

Fifty-six stroke patients receiving inpatient treatment will be evaluated. In addition, patients who have visited the outpatient clinic and have already undergone BMD scanning for osteoporosis screening, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be randomly included in the study.